EA200000548A1 - Сфероиды, способ получения и фармацевтические композиции - Google Patents

Сфероиды, способ получения и фармацевтические композиции

Info

Publication number
EA200000548A1
EA200000548A1 EA200000548A EA200000548A EA200000548A1 EA 200000548 A1 EA200000548 A1 EA 200000548A1 EA 200000548 A EA200000548 A EA 200000548A EA 200000548 A EA200000548 A EA 200000548A EA 200000548 A1 EA200000548 A1 EA 200000548A1
Authority
EA
Eurasian Patent Office
Prior art keywords
spheroids
producing
pharmaceutical compositions
pharmaceutical preparations
present
Prior art date
Application number
EA200000548A
Other languages
English (en)
Other versions
EA003324B1 (ru
Inventor
Патрис Дебрежа
Жерар Ледюк
Паскаль Ури
Паскаль Сюпли
Original Assignee
Лаборатуар Де Продюи Этик Этифарм
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Лаборатуар Де Продюи Этик Этифарм filed Critical Лаборатуар Де Продюи Этик Этифарм
Publication of EA200000548A1 publication Critical patent/EA200000548A1/ru
Publication of EA003324B1 publication Critical patent/EA003324B1/ru

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/485Morphinan derivatives, e.g. morphine, codeine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2095Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

(57) Настоящее изобретение относится к новой галеновой форме в виде сфероидов, содержащей одно или несколько действующих начал, за исключением тиагабина. Настоящее изобретение относится, кроме того, к способу получения таких сфероидов и к многокомпонентным фармацевтическим препаратам, таким как таблетки, содержащим эти сфероиды. Эти фармацевтические препараты предназначены для высвобождения содержащихся в них сфероидов и характеризуются отсутствием изменения профиля высвобождения действующего начала или действующих начал вследствие возможной стадии прессования.Международная заявка была опубликована вместе с отчетом о международном поиске.
EA200000548A 1997-11-21 1998-11-19 Сфероиды, способ получения и фармацевтические композиции EA003324B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9714631A FR2771291B1 (fr) 1997-11-21 1997-11-21 Spheroides, procede de preparation et compositions pharmaceutiques
PCT/IB1998/001911 WO1999026608A1 (fr) 1997-11-21 1998-11-19 Spheroides, procede de preparation et compositions pharmaceutiques

Publications (2)

Publication Number Publication Date
EA200000548A1 true EA200000548A1 (ru) 2000-12-25
EA003324B1 EA003324B1 (ru) 2003-04-24

Family

ID=9513635

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200000548A EA003324B1 (ru) 1997-11-21 1998-11-19 Сфероиды, способ получения и фармацевтические композиции

Country Status (29)

Country Link
US (1) US6077544A (ru)
EP (1) EP1032374B1 (ru)
JP (1) JP2001523706A (ru)
KR (1) KR100502938B1 (ru)
CN (1) CN1223341C (ru)
AT (1) ATE246496T1 (ru)
AU (1) AU744580B2 (ru)
BG (1) BG65117B1 (ru)
BR (1) BR9814672A (ru)
CA (1) CA2310147C (ru)
CZ (1) CZ299110B6 (ru)
DE (1) DE69817010T2 (ru)
DK (1) DK1032374T3 (ru)
EA (1) EA003324B1 (ru)
ES (1) ES2203989T3 (ru)
FR (1) FR2771291B1 (ru)
HR (1) HRP20000323B1 (ru)
HU (1) HU230053B1 (ru)
IL (2) IL136215A0 (ru)
MX (1) MXPA00004959A (ru)
NO (1) NO329728B1 (ru)
NZ (1) NZ504662A (ru)
PL (1) PL193878B1 (ru)
PT (1) PT1032374E (ru)
SK (1) SK284493B6 (ru)
TR (1) TR200002130T2 (ru)
WO (1) WO1999026608A1 (ru)
YU (1) YU31000A (ru)
ZA (1) ZA9810631B (ru)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2790668B1 (fr) * 1999-03-12 2002-07-26 D B F Granules contenant une substance vegetale et leur procede de preparation
CN1190185C (zh) 1999-04-06 2005-02-23 埃迪克埃迪法姆药品实验室 可饮用布洛芬药物悬浮液
FR2794646B1 (fr) * 1999-06-09 2001-09-21 Ethypharm Lab Prod Ethiques Microgranules de sulfate de morphine, procede de preparation et composition les contenant
DK1414956T3 (da) 2001-06-22 2008-03-03 Genencor Int Höjt påvirkningsresistente granula
AR034813A1 (es) 2001-07-20 2004-03-17 Novartis Ag Composiciones farmaceuticas y uso de las mismas
FR2830447B1 (fr) * 2001-10-09 2004-04-16 Flamel Tech Sa Forme galenique orale microparticulaire pour la liberation retardee et controlee de principes actifs pharmaceutiques
US8101209B2 (en) 2001-10-09 2012-01-24 Flamel Technologies Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles
FR2837100B1 (fr) * 2002-03-18 2004-07-23 Flamel Tech Sa Comprimes a bases de microcapsules a liberation modifiee
ATE419840T1 (de) 2002-04-09 2009-01-15 Flamel Tech Sa Orale wässrige suspension, mikrokapseln enthaltend, zur kontrollierten freisetzung von wirkstoffen
ES2314227T7 (es) * 2002-04-09 2012-11-19 Flamel Technologies Formulacion farmaceutica oral en forma de suspension acuosa de microcapsulas que permiten la liberacion modificada de amoxilicina.
FR2838647B1 (fr) * 2002-04-23 2006-02-17 Particules enrobees a liberation prolongee, leur procede de preparation et comprimes les contenant
US20040013737A1 (en) * 2002-07-19 2004-01-22 Philippe Becourt Taste masked oral composition of telithromycin
FR2845289B1 (fr) * 2002-10-04 2004-12-03 Ethypharm Sa Spheroides, procede de preparation et compositions pharmaceutiques.
US9107804B2 (en) 2002-12-10 2015-08-18 Nortec Development Associates, Inc. Method of preparing biologically active formulations
NZ523946A (en) 2003-01-31 2004-06-25 Carl Ernest Alexander Portable hygiene compositions comprising a semi-solid gel and active ingredients in bead form for use in personal oral, dental or skin care
ES2221804B1 (es) * 2003-06-18 2006-04-01 Lipofoods, S.L. Microcapsulas para la administracion de ingredientes activos.
WO2005034923A1 (en) * 2003-10-10 2005-04-21 Ethypharm Sustained-release microgranules containing gingko biloba extract and the process for manufacturing these
FR2861990B1 (fr) 2003-11-10 2006-02-10 Nouveaux Produits Pharma Comprimes faiblement doses a reseau de polymeres
ATE378042T1 (de) * 2004-04-12 2007-11-15 Pfizer Prod Inc Arzneiimittel mit verdecktem geschmack in aufbrechenden multipartikeln
WO2005123042A1 (en) * 2004-06-10 2005-12-29 Glatt Air Techniques, Inc. Controlled release pharmaceutical formulation
FR2883179B1 (fr) 2005-03-18 2009-04-17 Ethypharm Sa Comprime enrobe
US20070286900A1 (en) * 2006-06-09 2007-12-13 Catherine Herry Low dose tablets of opioid analgesics and preparation process
US20100233257A1 (en) * 2006-06-09 2010-09-16 Ethypharm Low dose sublingual tablets of opioid analgesics and preparation process
US11116728B2 (en) 2006-11-30 2021-09-14 Bend Research, Inc. Multiparticulates of spray-coated drug and polymer on a meltable core
WO2008065504A1 (en) * 2006-11-30 2008-06-05 Pfizer Products Inc. Multiparticulates of spray-coated drug and polymer on a meltable core
EP2468263A1 (en) 2010-12-23 2012-06-27 Laboratorios Del. Dr. Esteve, S.A. Compressed solid dosage forms
CN112118920B (zh) 2018-05-11 2023-04-14 斯多里机械有限责任公司 驱动组件
WO2019217607A2 (en) 2018-05-11 2019-11-14 Stolle Machinery Company, Llc Infeed assembly quick change features
CN112154037B (zh) 2018-05-11 2022-12-13 斯多里机械有限责任公司 快速更换工具组件
US11208271B2 (en) 2018-05-11 2021-12-28 Stolle Machinery Company, Llc Quick change transfer assembly
CN115673132A (zh) 2018-05-11 2023-02-03 斯多里机械有限责任公司 成型站和缩颈机
EP3791168A4 (en) 2018-05-11 2021-08-18 Stolle Machinery Company, LLC ARRANGEMENT FOR A COMPLETE INSPECTION OF THE FEEDER ASSEMBLY
JP7312196B2 (ja) 2018-05-11 2023-07-20 ストール マシーナリ カンパニー,エルエルシー 回転マニホールド
US11420242B2 (en) 2019-08-16 2022-08-23 Stolle Machinery Company, Llc Reformer assembly

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4684516A (en) * 1983-08-01 1987-08-04 Alra Laboratories, Inc. Sustained release tablets and method of making same
NZ230763A (en) * 1988-09-27 1991-10-25 Takeda Chemical Industries Ltd Production of granules having a core by spraying the cores with a dispersion of hydroxypropylcellulose, optionally incorporating an active ingredient
EP0418596A3 (en) * 1989-09-21 1991-10-23 American Cyanamid Company Controlled release pharmaceutical compositions from spherical granules in tabletted oral dosage unit form
JP2572673B2 (ja) * 1990-07-25 1997-01-16 エスエス製薬株式会社 徐放性錠剤
FR2679451B1 (fr) * 1991-07-22 1994-09-09 Prographarm Laboratoires Comprime multiparticulaire a delitement rapide.
GB9117361D0 (en) * 1991-08-12 1991-09-25 Euro Celtique Sa Oral dosage form
FR2692146B1 (fr) * 1992-06-16 1995-06-02 Ethypharm Sa Compositions stables de microgranules d'omeprazole gastro-protégés et leur procédé d'obtention.
DE69405752T2 (de) * 1993-06-14 1998-02-05 Janssen Pharmaceutica Nv Filmbeschichtete tablette von astemizol und pseudoephedrin mit verlängerter freigabe
SE9402422D0 (sv) * 1994-07-08 1994-07-08 Astra Ab New beads for controlled release and a pharmaceutical preparation containing the same
SE9600070D0 (sv) * 1996-01-08 1996-01-08 Astra Ab New oral pharmaceutical dosage forms
FR2771292B1 (fr) * 1997-11-21 2000-02-18 Ethypharm Lab Prod Ethiques Spheroides contenant de la tiagabine, procede de preparation et compositions pharmaceutiques

Also Published As

Publication number Publication date
CA2310147C (fr) 2010-05-25
IL136215A (en) 2006-12-31
EA003324B1 (ru) 2003-04-24
KR100502938B1 (ko) 2005-07-25
HUP0100562A2 (hu) 2002-05-29
MXPA00004959A (es) 2002-10-17
NO20002605D0 (no) 2000-05-19
PL193878B1 (pl) 2007-03-30
DE69817010T2 (de) 2004-05-27
ZA9810631B (en) 1999-05-24
NZ504662A (en) 2002-09-27
FR2771291A1 (fr) 1999-05-28
DK1032374T3 (da) 2003-11-24
WO1999026608A1 (fr) 1999-06-03
PT1032374E (pt) 2003-12-31
BR9814672A (pt) 2000-10-03
HUP0100562A3 (en) 2002-08-28
YU31000A (sh) 2002-11-15
JP2001523706A (ja) 2001-11-27
CZ299110B6 (cs) 2008-04-23
CA2310147A1 (fr) 1999-06-03
BG104511A (en) 2001-04-30
ATE246496T1 (de) 2003-08-15
EP1032374A1 (fr) 2000-09-06
CZ20001849A3 (cs) 2000-10-11
AU744580B2 (en) 2002-02-28
FR2771291B1 (fr) 2000-02-25
DE69817010D1 (de) 2003-09-11
PL340659A1 (en) 2001-02-12
SK284493B6 (sk) 2005-05-05
HRP20000323B1 (en) 2006-07-31
ES2203989T3 (es) 2004-04-16
HU230053B1 (hu) 2015-06-29
CN1223341C (zh) 2005-10-19
EP1032374B1 (fr) 2003-08-06
NO329728B1 (no) 2010-12-06
KR20010032329A (ko) 2001-04-16
AU1170499A (en) 1999-06-15
HRP20000323A2 (en) 2001-06-30
US6077544A (en) 2000-06-20
TR200002130T2 (tr) 2000-12-21
NO20002605L (no) 2000-07-05
IL136215A0 (en) 2001-05-20
SK7562000A3 (en) 2001-06-11
CN1282239A (zh) 2001-01-31
BG65117B1 (bg) 2007-03-30

Similar Documents

Publication Publication Date Title
EA200000548A1 (ru) Сфероиды, способ получения и фармацевтические композиции
ATE429210T1 (de) Orale flüssige zusammensetzungen
NO954342L (no) Erytropoietinanalogblandinger, samt fremgangsmåter ved fremstilling derav
ATE146360T1 (de) Gonadotropin enthaltende gefriergetrocknete troepfen
NL980012I2 (nl) Mometasonfuroaat-monohydraat, werkwijze om zulks te bereiden en farmaceutische samenstellingen.
ATE468126T1 (de) Ingwer-extraktzubereitung
ES2173638T3 (es) Esferoides que contienen tiagabina, procedimiento de fabricacion y composiciones farmaceuticas.
AR022358A1 (es) Una composicion de epo, un procedimiento para su obtencion, un preparado farmaceutico que la contiene y un procedimiento para aumentar la actividadespecifica de una composicion de epo
DE69033970T2 (de) Huperzin a analoge verbindungen
DE69836678D1 (de) Chinolin- und chinazolinderivate als antagonisten des corticotropin freisetzenden faktors (crf)
DE69613395D1 (de) Schwefelenthaltende di-ter-butylphenol-verbindungen brauchbar als entzündungshemmende mittel
ATE106883T1 (de) Azelastin-embonat, verfahren zu seiner herstellung und pharmazeutische zubereitungen, die als wirkstoff azelastin-embonat enthalten.
DE69602208D1 (de) Stabilisierte pharmazeutische zusammensetzungen enthaltend dobutamine

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM